Integro Technologies Corp. – Trademark Portfolio
Entity Type: 03
Integro Technologies Corp. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include VISION+, VISIONVAULT, and WE SEE WHAT OTHERS CAN'T!. The owner is based in Salisbury, NC.
Suite 200
301 South Main Street
Salisbury, NC 28144
Showing of trademarks Trademarks
Trademark Classifications
Integro Technologies Corp.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does Integro Technologies Corp. have?
Integro Technologies Corp. has 8 U.S. trademarks filed with the USPTO. Of these, 3 registered, 5 abandoned.
What trademark classes does Integro Technologies Corp. file in?
Integro Technologies Corp. files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 7 (Machinery). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Integro Technologies Corp.'s most well-known trademarks?
Integro Technologies Corp.'s registered trademark portfolio includes well-known marks such as VISION+, VISIONVAULT, and WE SEE WHAT OTHERS CAN'T!. These are among 3 currently registered trademarks in the portfolio.
What is Integro Technologies Corp.'s trademark registration success rate?
Integro Technologies Corp. has a 38% trademark registration rate, with 3 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.